Home › COPD › West Virginia › Morgantown
COPD clinical trials in Morgantown, WV
4 studies for COPD are looking for participants at sites in and around Morgantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, Morgantown
- Research Site, Smithfield · 14 mi away
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RecruitingPhase 3
- GSK Investigational Site, Morgantown
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RecruitingPhase 3
- Research Site, Morgantown
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Recruiting
- West Virginia Clinical and Translational Science Institute, Morgantown
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA26 studies
- Miami, FL20 studies
- Houston, TX18 studies
- Birmingham, AL17 studies
- Baltimore, MD16 studies
- Boston, MA15 studies
- Orlando, FL15 studies
- Chicago, IL15 studies
- Dallas, TX13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Winston-Salem, NC11 studies
Other studies in Morgantown
- Non-Small Cell Lung Cancer12 studies
- Ovarian Cancer11 studies
- Breast Cancer11 studies
- Type 2 Diabetes7 studies
- Cardiovascular Disease7 studies
- Cancer (all types)6 studies
- Metastatic Cancer6 studies
- Heart Failure6 studies
- Lung Cancer6 studies
- Obesity5 studies
- Melanoma5 studies
- Colon Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.